In cancer cells [49] and neurons [50], the non-collagenous C-terminal domain (NC1) of collagen XIX (cleaved by plasmin) can modulate cell responses via binding and signaling through RGD-dependent integrins (including αvβ3 and α5β1). Here, PLG is linked to cancer.